XML 54 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of estimated fair value of derivatives measured by level of fair value hierarchy
The Company’s financial assets and liabilities measured and reported at fair value on a recurring basis include the following as of:
September 30, 2020December 31, 2019
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Derivative assets(1)
$— $13 $— $13 $— $479 $— $479 
Derivative liabilities(2)
$— $(11,793)$— $(11,793)$— $(1,791)$— $(1,791)
Non-real estate investments(1)
$— $4,216 $— $4,216 $— $5,545 $— $5,545 
___________ 
1.Included in the prepaid expenses and other assets, net line item on the Consolidated Balance Sheets.
2.Included in the accounts payable, accrued liabilities and other line item on the Consolidated Balance Sheets.
Schedule of carrying value and fair value of notes payable
The table below represents the carrying value and fair value of the Company’s investment in securities and debt as of:
September 30, 2020December 31, 2019
Carrying Value
Fair Value
Carrying Value
Fair Value
ASSETS
U.S. Government securities$136,649 $144,270 $140,749 $144,589 
LIABILITIES
Unsecured debt(1)
$1,925,000 $2,037,138 $2,475,000 $2,540,606 
Secured debt(1)
$1,162,168 $1,156,377 $370,459 $366,476 
In-substance defeased debt$132,560 $131,898 $135,030 $134,936 
Joint venture partner debt$66,136 $67,789 $66,136 $68,557 
_________________
1.Amounts represent debt excluding net deferred financing costs.